In the News
Browse news coverage related to Lupus Ventures, lupus breakthroughs, and progress in autoimmune disease discovery. If you are a member of the media seeking information or interviews, please contact Margy Meislin at MMeislin@lupusresearch.org.
- Immunology Market Size, Share & Industry Analysis
- Lupus Research Alliance Funds Study to Understand Connection between the Common Epstein-Barr Virus and Lupus
- Lupus Clinical Research: A New Wave of Innovation
- GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline
- Lupus Research Alliance Showcases Research that will Shape Next Generation Treatments at ACR Convergence 2025
- Lupus Research Alliance Applauds U.S. FDA Approval of Gazyva® (Obinutuzumab) for Lupus Nephritis
- FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis
- Lupus Research Alliance Announces 2025 Empowering Lupus Research Award Recipients to Support Breakthroughs
- BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding
- Systemic Lupus Erythematosus Pipeline Heats Up as 120+ Companies Advance Cutting-Edge Therapies
- Lupus R&D has come a long way, and the next breakthroughs could come from cell therapy
- Private biotech: Immunology and inflammation’s third wave
- Merck bets $700M on an antibody drug’s potential in immune diseases
- Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
- Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed to Address Immune Dysfunction
- Changing of the guard: Immunology at an inflection point
July 20, 2026